Psoriasis and Ipf

Summary:

Ipf is found among people with Psoriasis, especially for people who are female, 60+ old.

The study analyzes which people have Ipf with Psoriasis. It is created by eHealthMe based on reports of 789 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,526 drugs and 1,668 conditions by eHealthMe. Check the latest studies of Psoriasis.

What is Ipf?

Ipf is found to be associated with 2,164 drugs and 2,245 conditions by eHealthMe. Check the latest studies of Ipf.



On Oct, 11, 2025

789 people who have Psoriasis and Ipf are studied.

Would you have Ipf when you have Psoriasis?

Gender of people who have Psoriasis and experienced Ipf *:

  • female: 70.5 %
  • male: 29.5 %

Age of people who have Psoriasis and experienced Ipf *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.39 %
  • 40-49: 31.08 %
  • 50-59: 27.61 %
  • 60+: 40.93 %

Common co-existing conditions for these people *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 423 people, 53.61%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 300 people, 38.02%
  3. Adenomatous Polyposis Coli ((fap) is an inherited condition in which numerous polyps form mainly in the epithelium of the large intestine): 95 people, 12.04%
  4. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 68 people, 8.62%
  5. Ankylosing Spondylitis (type of arthritis affecting the spine): 54 people, 6.84%
  6. Stress And Anxiety: 53 people, 6.72%
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints): 51 people, 6.46%
  8. Indigestion: 48 people, 6.08%
  9. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 40 people, 5.07%
  10. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 27 people, 3.42%

Common drugs taken by these people *:

  1. Humira: 443 people, 56.15%
  2. Orencia: 408 people, 51.71%
  3. Cimzia: 408 people, 51.71%
  4. Enbrel: 401 people, 50.82%
  5. Xeljanz: 400 people, 50.70%
  6. Remicade: 399 people, 50.57%
  7. Actemra: 398 people, 50.44%
  8. Simponi: 398 people, 50.44%
  9. Arava: 390 people, 49.43%
  10. Methotrexate: 376 people, 47.66%

Common symptoms for these people *:

  1. Fatigue (feeling of tiredness): 426 people, 53.99%
  2. High Blood Pressure: 422 people, 53.49%
  3. Nausea (feeling of having an urge to vomit): 419 people, 53.11%
  4. Pain: 390 people, 49.43%
  5. Arthropathy: 385 people, 48.80%
  6. Mobility Decreased (ability to move is reduced): 378 people, 47.91%
  7. Drug Ineffective: 372 people, 47.15%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 370 people, 46.89%
  9. Synovitis (inflammation of the synovial membrane): 364 people, 46.13%
  10. Drug Intolerance (drug sensitivity): 357 people, 45.25%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ipf?

Check whether Ipf is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Ipf:

  • Ipf (2,164 drugs)

All the conditions that are associated with Ipf:

  • Ipf (2,245 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Ipf and Psoriasis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: